Role of insulin-like growth factor-I in primary osteoporosis: A correlative study

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03343711PMID 10853706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women

  2004cited by this paper
• Gender Differences in Insulin‐like Growth Factor and Bone Mineral Density Association in Old Age: The Rancho Bernardo Study

  1998cited by this paper
• Insulin-like growth factor-I in men with idiopathic osteoporosis.

  1997cited by this paper
• Serum Levels of Insulin‐like Growth Factor (IGF) I, IGF‐Binding Protein (IGFBP)‐2, and IGFBP‐3 in Osteoporotic Patients with and without Spinal Fractures

  1997cited by this paper
• Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

  1996cited by this paper
• Insulin-like growth factor I: physiology, metabolic effects and clinical uses.

  1996cited by this paper
• Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.

  1996cited by this paper
• Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.

  1996cited by this paper
• Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.

  1995cited by this paper
• Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.

  1995cited by this paper
• Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis

  1993cited by this paper
• Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosis

  1992cited by this paper
• Diagnosis of Osteoporosis

  1992cited by this paper
• Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.

  1992cited by this paper
• Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults.

  1991cited by this paper
• The effects of estrone (Ogen) on spinal bone density of postmenopausal women.

  1991cited by this paper
• Pathophysiology of Polycystic Ovary Syndrome

  1990cited by this paper
• Effects of short term administration of recombinant human growth hormone to elderly people.

  1990cited by this paper
• Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis?

  1990cited by this paper
• Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments.

  1989cited by this paper
• Involutional osteoporosis.

  1986cited by this paper
• Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.

  1985cited by this paper
• Growth Hormone, Body Composition, and Aging

  1985cited by this paper

• Re-engineering bone: pathogenesis, diagnosis and emerging therapies for osteoporosis.

  2025cites this paper
• Calcitriol treatment in patients with low vitamin D levels

  2018cites this paper
• The association between the IGF-I axis, thyroid hormones and cortical bone in patients with mild primary hyperparathyroidism

  2013cites this paper
• Potential Role of Arginine, Glutamine and Taurine in Ameliorating Osteoporotic Biomarkers in Ovariectomized Rats

  2009cites this paper
• Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities.

  2008cites this paper
• CHAPTER 57 – The Acid-Base Effects of the Contemporary Western Diet: An Evolutionary Perspective

  2008cites this paper
• Somatomedin C (IGF-1), Dehydroepiandrosterone Sulphate (DHEA-S) and Hcy Metabolism in Postmenopausal African Women

  2006cites this paper
• Tissue Engineering of Craniofacial Structure

  2005cites this paper
• Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.

  2004cites this paper
• Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.

  2003cites this paper
• Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.

  2003cites this paper
• Pathophysiological and Clinical Importance of Insulin-Like Growth Factor-I with Respect to Bone Metabolism

  2003cites this paper
• [Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer].

  2003cites this paper
• Fracture risk is increased in patients with GH deficiency or untreated prolactinomas – a case‐control study

  2002cites this paper
• Pathophysiologie der Primären Osteoporose

  2001cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Skeletal Health1

  2001cites this paper
• Parathyroid hormone: an anabolic treatment for osteoporosis.

  2001cites this paper
• The DHEA Debate A critical review of clinical and experimental data

  year unknowncites this paper